#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

T-buněčný lymfom

Brentuximab Vedotin as Another Therapeutic Option in Cutaneous T-Cell Lymphoma

4. 1. 2022 Source: Hematologic Malignancies

Current systemic treatment for patients with cutaneous T-cell lymphoma (CTCL) unfortunately has limited efficacy, achieving low response rates and short-lasting remissions. Moreover, there is no curative therapy modality for advanced stages of CTCL. However, the results of the recently concluded ALCANZA clinical trial indicate the potential of brentuximab vedotin in this indication.

guidelines

Current Recommendations of the Expert Panel on the Management of von Willebrand Disease

Von Willebrand disease (vWD) is a common congenital bleeding disorder. The care of patients with…
4. 1. 2022 Source: Von Willebrand Disease
Starší doktor u počítače vysvětluje mladé pacientce její zdravotní stav.

How and with What the National Registry of Primary Immunodeficiencies Benefits Specialists and Patients

Primary immunodeficiencies constitute a very heterogeneous group of congenital diseases. They…
3. 1. 2022 Source: Hereditary Angioedema
rakovina buňky

Update of the Blue Book: What's New in the Treatment of Metastatic NSCLC with an ALK Gene Mutation?

As of March 1, 2022, the 28th update of the Blue Book by the Czech Society for Oncology of ČLS JEP…
27. 12. 2021 Source: Genetic Profile and Treatment of NSCLC
Brain metastases

Brain Metastases Are Not an Absolute Contraindication for Antiplatelet Therapy

On one hand, there's a higher risk of thromboembolic events, and on the other, a higher risk of…
27. 12. 2021 Source: Genetic Profile and Treatment of NSCLC
cancer plíce

Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy –⁠ a case study

Targeted treatment for driving oncogenic mutations has significantly improved outcomes for patients…
27. 12. 2021 Source: Genetic Profile and Treatment of NSCLC
covid očkování medicína doktor

How Do Vaccinated MS Patients Fare with COVID-19 Antibodies?

Which disease-modifying drugs for the treatment of multiple sclerosis (MS) reduce the humoral…
21. 12. 2021 Source: Multiple Sclerosis
výzkum lékař medicína laboratoř

When Teriflunomide and Interferon Join Forces

Progressive multifocal leukoencephalopathy is a nightmare for all doctors prescribing…
21. 12. 2021 Source: Multiple Sclerosis
molekuly

Fixed Combination of Tiotropium/Olodaterol in SMI Inhaler and Its Benefits in COPD Treatment

The TRONARTO study, whose conclusions were published in the International Journal of Chronic…
20. 12. 2021 Source: COPD
mladá žena u gynekologa

Protection of Ovarian Function During Breast Cancer Treatment

Women diagnosed with breast cancer of childbearing age are concerned about how to maintain ovarian…
20. 12. 2021 Source: Oncological Treatment
1 90 91 92 93 94 168
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#